REFRACTORY HAIRY CELL LEUKEMIA
Clinical trials for REFRACTORY HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses chemotherapy and radiation before donor stem cells are given, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer a…
Matched conditions: REFRACTORY HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug flotetuzumab tested for tough blood cancers
Disease control CompletedThis early-stage trial tested the safety and best dose of flotetuzumab, a lab-made antibody, in 13 people with advanced blood cancers that had come back or stopped responding to treatment. The goal was to see if the drug could help control the disease by blocking cancer cell grow…
Matched conditions: REFRACTORY HAIRY CELL LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 04, 2026 16:18 UTC